Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Dynasil Corp. of America

Facebook Twitter LinkedIn Email Comments
Dynasil Corp. of America, based in Watertown, Mass., has incorporated a business unit, Dynasil Biomedical Corp., in Rochester, Minn., to pursue opportunities in the field. Daniel Ericson has joined the new unit as its scientific leader with responsibility for research and development. The unit purchased for $300,000 Ericson’s rights to six biomedical technologies invented or co-invented by him, as well as certain rights to royalties and milestone payments if the technologies are successfully developed. Several of the technologies are jointly owned with the Mayo Clinic, where Ericson previously worked. All in the early stage of development, the inventions include a tuberculosis test, a tissue sealant and diagnostic tests using handheld optical detection systems. The unit will collaborate with Dynasil’s RMD Research organization and its RMD Instruments business.


BioPhotonics
Jul 2011
Americasbiomedical technologiesBiophotonicsblood coagulationBusinesscardiovascular risksDaniel EricsonDynasil Biomedical Corp.Dynasil Corporation of AmericahemophiliaimagingMassachusettsMayo ClinicMinnesotaoptical detection systemspoint-of-care diagnosticsRapidScanRMD InstrumentsRMD Researchtissue sealanttuberculosis test

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]cs.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.